The cytotoxic T lymphocyte (CTL) activity of spleen cells from BALB/c (H-2d) mice immunized with the neurotropic JHM strain of mouse hepatitis virus (JHMV) was stimulated in vitro for 7 days. CTL were tested for recognition of target cells infected with either JHMV or vaccinia virus recombinants expressing the four virus structural proteins. Only target cells infected with either JHMV or the vaccinia virus recombinant expressing the JHMV nucleocapsid protein were recognized. Cytotoxic T cell lines were established by limiting dilution from the brains of mice undergoing acute demyelinating encephalomyelitis after infection with JHMV. Twenty of the 22 lines recognized JHMV-infected but not uninfected syngeneic target cells, indicating that they are specific for JHMV. All T-cell lines except one were CD8+. The specificity of the CTL lines was examined by using target cells infected with vaccinia virus recombinants expressing the JHMV nucleocapsid, spike, membrane, and hemagglutinin-esterase structural proteins. Seventeen lines recognized target cells expressing the nucleocapsid protein. Three of the JHMV-specific T-cell lines were unable to recognize target cells expressing any of the JHMV structural proteins, indicating that they are specific for an epitope of a nonstructural protein(s) of JHMV. These data indicate that the nucleocapsid protein induces an immunodominant CTL response. However, no CTL activity specific for the nucleocapsid protein could be detected in either the spleens or cervical lymph nodes of mice 4, 5, 6, or 7 days after intracranial infection, suggesting that the CTL response to JHMV infection within the central nervous system may be induced or expanded locally.
Infection of rodents with the neurotropic JHM strain of mouse hepatitis virus (JHMV) results in a panencephalitis accompanied by extensive demyelination (14, 21, 25, 47, 49) . Histological analyses of the central nervous system (CNS) show infiltration by mononuclear cells and primary demyelination (25, 49) . The primary demyelination is characterized by macrophage-mediated removal of myelin and the preservation of axonal integrity. The mechanism of injury is cytolytic infection of oligodendroglial cells (25) ; however, an immunological component has recently been implicated (46) .
The interaction of the immune response, the virus, and the cells of the CNS is not well understood. JHMV infection results in an acute phase characterized by viral growth prior to the recruitment of mononuclear cells into the CNS. Reductions in infectious virus are accompanied by a generalized panencephalitis and demyelination (25, 49) . Survivors of subacute infections show evidence of chronic ongoing demyelination associated with the persistence of virus within the CNS (29, 42) . Therefore, JHMV infection has been studied as a model for both the acute and chronic forms of virus-induced demyelination. The pathological changes in the CNS of rodents infected with JHMV have a number of features in common with multiple sclerosis, and indeed, recent evidence has suggested an association between coronaviruses and multiple sclerosis (28, 38) .
To understand the relationships between JHMV, the CNS, and the immune response of the host, a number of studies have examined the ability of virus mutants to produce demyelina-* Corresponding author.
tion. These studies indicate that the spike (S) protein, which is the ligand for both neutralizing antibodies (2, 13, 48) and the cell surface receptor (10) , plays a major role in the ability of JHMV to infect specific cell types within the CNS and produce demyelination (11, 14, 15) . The role of the host immune response in suppressing virus replication, contributing to the characteristic virus-specific demyelination and resulting in viral persistence, is less clear. JHMV infection of immunologically compromised hosts indicates that immunity controls virus replication (3, 37, 43, 46) and, by inference, the ability of the virus to produce lesions within the CNS. Consistent with their role in controlling virus replication, neutralizing monoclonal antibodies (MAb) specific for the S protein protect against a lethal challenge (2, 48). Lethal infections can also be prevented by the passive transfer of MAb specific for nonneutralizing epitopes of the structural proteins; however, these MAb have little or no effect on virus replication or subsequent pathological changes within the CNS (12, 30, 56) .
Analysis of the cells infiltrating the CNS during JHMV infection has shown that activated B cells, T cells, natural killer cells, and monocytes are all present within the CNS (9, 51, 53) . In vivo depletion of T-cell subsets revealed that both CD4+ and CD8+ T cells are involved in the reduction of virus within the CNS and protection from acute disease (52) . However, adoptive transfers have shown that virus clearance is associated with CD8+ T cells restricted to major histocompatibility (MHC) class I molecules (44) . These data were interpreted to indicate that a CD4+ helper activity is required for the generation of cytotoxic CD8+ T cells, which represent the primary effectors of JHMV clearance from the CNS (44) . These data are also consistent with studies in which the adoptive transfer of virus-specific Thl CD4+ T cells were found to protect against lethal infection (41) ; however, more recent data have shown a partial reduction in virus titer in the CNS after adoptive transfer of Thl clones (19, 55) (13) .
Synthetic peptides and oligonucleotides. Peptide pN3 18-335, which contains the L"-restricted N protein epitope (APTAGAFFFGSKLELVKK), was synthesized on an automated model 430A synthesizer (Applied Biosystems, Foster City, Calif.), and purity was assessed by high-pressure liquid chromatography (HPLC) as described previously (1) . Oligonucleotides were synthesized on a model 394 DNA synthesizer (Applied Biosystems).
Induction of secondary CTL. Spleen cell suspensions were prepared from mice immunized 2 to 4 weeks earlier by intraperitoneal injection of 10' PFU of JHMV (40) . Spleen cells from immune mice were cultured for 6 days at 37°C in 40 ml of RPMI 1640 medium supplemented with 2 mM glutamine, 25 pLg of gentamicin per ml, 1 mM sodium pyruvate, 5 x 10-5 M 3-2-mercaptoethanol, nonessential amino acids (RPMI complete), and 10% fetal calf serum (FCS; Gemini Bioproducts) with irradiated (2,500 rads) syngeneic spleen cells derived from naive mice which were infected with JHMV at an MOI of 0.10 to 0.05 as described previously (40) 10) . After incubation for 6 h at 37°C, the target cells were washed twice in RPMI 1640, and 106 cells were labeled by incubation in 100 p.Ci of Na5'CrO4 (New England Nuclear) in a volume of 100 p.l for 1 h at 37°C, washed four times, and resuspended in RPMI 1640 containing 5% FCS. Target cells at a concentration of 1(4 in a 100-pi volume were added to the effector cells. In some experiments, target cells were preincubated for 30 min at 37°C with peptide (pN318-335), which has recently been shown to contain the immunodominant L'-restricted N protein epitope (1) . After 4 h of incubation at 370C, 100 pl of supernatant was removed, and the radioactivity was determined in a gamma counter. Data are expressed as percent specific release, defined as (experimental release -spontaneous release)/(detergent release -spontaneous release). Maximum spontaneous release values were <20% of total release values.
Isolation of T-cell lines. To isolate cytotoxic T-cell lines from mice undergoing acute infection with JHMV, brains were removed at 7 days p.i. and pressed through 200-p.m Nitex gauze (Tetko, Lancaster, Pa.) and single cells were isolated from the 30%-68% interface of Percoll step gradients as described previously (52) . Viable cells were further isolated by centrifugation on Lympholyte M (Accurate Chemicals, San Diego, Calif.). After two washes in RPMI, the cells were suspended in RPMI complete containing 5% FCS, and adherent cells were removed by incubation on plastic petri dishes for 2 h at 37°C. Although adherence resulted in approximately 95% cell loss, T cells could not be expanded during four initial experiments in which this step was omitted. After vigorous washing, the nonadherent cells were recovered and incubated with syngeneic irradiated (2, Initial experiments demonstrated significant cytolytic activity specific for target cells infected with either JHMV or a VV recombinant expressing the S protein derived from the heterologous strain MHV-A59 (vAS). No cytolysis specific for any JHMV-encoded structural protein, including the N protein, could be detected. The majority of the cytolytic activity specific for JHMV-infected target cells, but not the activity specific for the target cells expressing the MHV-A59 strain S protein, could be removed by treatment of the effector population with anti-CD8 MAb plus complement (not shown).
B-cell-mediated cytotoxicity of target cells expressing the MHV-A59 S protein has been described previously (50); therefore, effector populations were depleted of B cells by panning and examined for JHMV-specific cytotoxicity. Panning removed -90% of the B cells, as determined by FACS analysis, and eliminated the cytotoxicity specific for the MHV-A59 S protein. Figure 3 shows the cytolytic activity of the untreated and B-cell-depleted spleen cells on target cells infected with JHMV and VV recombinants expressing the JHMV S (vJS) and N (vJN) proteins and the MHV-A59 S protein (vAS). No cytotoxicity could be detected for target cells infected with VV recombinants expressing either the JHMV S or N protein (Fig. 3) or the JHMV M or HE protein (data not shown). These data confirm the previous demonstration of B-cell-mediated cytolysis of MHV-A59-infected target cells (50, 54) with MAb plus complement (40) , and the viable cells were cloned at limiting dilution. Twenty-two cell lines were isolated and tested for recognition of JHMV-infected and uninfected J774.1 target cells. Figure 4 shows that two lines, designated BI and B2, could not distinguish infected from uninfected target cells, consistent with the activation of self-reactive T cells after JHMV infection (22) . The remaining 20 T-cell lines showed various levels of specific lysis of JHMV-infected target cells.
To determine which viral proteins were recognized by the JHMV-specific CTL lines, target cells infected with VV recombinants expressing the JHMV S, M, HE, and N structural proteins were tested for recognition at either two or three effector-to-target (E/T) ratios. In some experiments, the recently identified L'-restricted N protein-derived peptide pN318-335 (1) containing the CTL epitope, possibly due to the presence of 3' untranslated sequences (1, 40) . In addition, target cells coated with the pN318-335 peptide are more sensitive to CTL recognition than any of the VV recombinant-infected cells (1) .
Examples of the recognition patterns obtained for JHMVand VV recombinant-infected target cells are shown in Table  1 , and the complete characterization of all 22 lines is summarized in Table 2 (40) ; therefore, these data indicate that the L'trestricted response to the N protein is the immunodominant CTL response in the CNS of BALB/c mice undergoing acute JHMV infection. In addition, these data confirm the presence of a CTL response directed toward an epitope(s) contained within a nonstructural protein(s).
One cytolytic CD4+ T-cell line (822) was also isolated from the CNS of JHMV-infected mice (Tables I and 2 ). The B22 line exhibits a unique dual specificity of recognition. It recognizes target cells infected with JHMV (Table 1, Fig. 4 ) and with a VV recombinant expressing the MHV-A59 S protein (vAS) but not target cells infected with the VV recombinant expressing the JHMV S protein (vJS) (Fig. 5) . However, the cytolytic activity specific for the MHV-A59 S protein is not MHC class I restricted (data not shown), suggesting that this CD4+ line mediates lysis of the S protein-expressing target cells via interaction between the MHV-A59 S protein and its cell surface receptor. The recognition of the JHMV-infected targets but not of target cells infected with any of the VV recombinants expressing the virus structural proteins suggests that B22 recognizes an epitope encoded within a nonstructural protein. Neither of the other two CD8+ T cell lines (814 and B18), which recognize an epitope within a nonstructural protein(s), recognized target cells expressing the MHV-A59 S protein.
The different growth rates of the isolated lines propagated (16, 36) , and the CTL response to the N protein is exclusively L restricted (40) . The data in Table 2 show that 10 of the 15 N protein-specific CTL lines did indeed express v18.1/8.2 TCR. Two lines were unavailable for testing (B5 and B10), and one line (B3) was determined by FACS analysis not to be clonal, containing both KJ-16+ and KJ-16-CD8+ T cells. Analysis of the three lines specific for a (Table 2) .
Our previous data demonstrated that the KJ-16+ CTL lines B8 and B15 recognized peptide pN318-335, derived from the N protein, on Ld-expressing target cells (1) . The N protein contains a number of potential Ld-binding motifs (6) . To determine whether the KJ-16+ and KJ-16 -CTL lines had the same specificity, two additional KJ-16+ CTL lines (B11 and B21) and two KJ-16-lines (B9 and B19) were tested for recognition of J774.1 target cells coated with the pN318-335 peptide. Figure 6 shows that these four CTL lines recognize target cells incubated in the presence of half-saturating concentrations of peptide pN318-335 (5 nM). These data suggest that a single N protein-derived Ld-restricted epitope is recognized by both KJ-16' and KJ-16-CTL lines.
Absence of N protein-specific CTL in the CLN populations. To determine whether CTL specific for the N protein were present in the CLN, cells were isolated from the CLN of mice 7 days after i.c. infection with JHMV and tested directly for cytotoxic activity. Target cells infected with JHMV, VV recombinants expressing the MHV-A59 S protein (vAS) or the JHMV S protein (vJS), and target cells incubated with pN318-355 were examined. Figure 7A demonstrates the presence of cytolytic activity in the CLN cell population specific for JHMVinfected and MHV-A59 S protein-expressing target cells. Depletion of B cells eliminated the cytolytic activity specific for the MHV-A59 S protein but not the CTL activity specific for the target cells infected with JHMV (Fig. 7) . Depletion of CD8+ cells eliminated all JHMV-specific cytotoxicity (data not shown). As for the populations derived from the spleens of infected mice, no N protein-or S protein-specific CTL activity could be detected in the CLN population. In activity specific for targets expressing the JHMV M or HE protein was detected (data not shown).
The possibility that the CTL specific for the N protein in either the spleen or CLN populations were rapidly recruited to the CNS was examined by analysis of the spleen and CLN populations for N protein-specific CTL at 7, 6, 5, and 4 days p.i. Figure 7B shows that neither the spleen nor the CLN cells from mice infected 7 days previously recognize target cells either infected with the VV recombinant expressing amino acids 301 to 351 of the N protein (vJN51) or incubated with 100 nM pN318-335 peptide. Identical results were obtained from parallel analysis of spleen and CLN cells from mice infected 6, 5, and 4 days previously (data not shown). These data suggest that the N protein-specific CTL either are generated locally within the CNS or are present at extremely low levels within the peripheral lymphoid organs and recruited rapidly into the CNS.
DISCUSSION
Manipulations of the immune response of rodents infected with JHMV have shown both beneficial and detrimental effects (21) . The passive transfer of nonneutralizing MAb specific for structural proteins and the adoptive transfer of virus-specific CD4+ T cells are both able to prevent death from lethal infections. However, neither of these manipulations result in a significant alteration of virus replication within the CNS. The in vivo depletion of T-cell subsets during JHMV infection suggested that the initial clearance of virus from the CNS is mediated by a CD4 -CD8 population (52) . Natural killer cells were further implicated in this initial clearance by direct analysis of natural killer activity in mononuclear cell infiltrates obtained during the acute infection (53) . However, these studies also clearly showed that subsequent clearance of virus from the CNS requires both CD4+ and CD8+ T-cell populations (52) , consistent with the suggestion that induction of JHMV-specific CTL requires a CD4+ "helper" population (44) . Finally, the adoptive transfer of clonal populations of JHMV-specific CD8+ T cells is of therapeutic value, resulting in both protection from a lethal challenge and suppression of virus replication in the CNS (55), consistent with the hypothesis that CD8+ T cells play a major role in protection from JHMV-induced disease (44, 52) .
The present study demonstrates that the CTL response specific for the N protein constitutes a major JHMV-specific effector CTL population present both in mice immunized intraperitoneally and within the CNS of infected mice. The majority of the CTL isolated from the CNS of mice infected with JHMV are specific for the N protein and express the VP B cells from naive BALB/c mice exhibit cytotoxicity for cells infected with MHV-A59, resulting in death of both the target and the effector B cell (50) . This cytolytic activity can be blocked by antibody specific for the S protein, suggesting that the cytolysis is mediated by the interaction of the MHV-A59 S protein with a surface component expressed by the B cells. Recent data suggest that this cytolytic interaction is mediated by the interaction between the S protein and its ligand, the MHV receptor (10), on the B-cell population (18) . The data in the present report suggest that B-cell-mediated killing does not contribute significantly to the cytolytic activity directed against JHMV-infected targets, since the JHMV-specific cytolytic activity was not removed by B-cell depletion. Furthermore, our data suggest that some CD4+ T cells may also express the MHV receptor. One vp8.1/8.2-CD4+ cytolytic clone (B22) was isolated which recognizes JHMV-infected but not uninfected targets, demonstrating specificity for a viral component. helper activity (44, 52) . Although the present data do not contradict this hypothesis, they suggest that virus-specific CD4+ cytolytic T cells may contribute directly to the reduction of JHMV during infection within the CNS.
The absence of detectable N protein-specific CTL in both the spleen and CLN during JHMV infection may provide new insights into the interactions between the immune system and the CNS. N protein-specific CTL could not be detected in the spleen or CNL from days 4 to 7 p.i., even in the extremely sensitive peptide-coated target assay system (1) . These data suggest either that the number of N protein-specific CTL in the spleen and CLN is too low to be detected or that these CTL are rapidly recruited and expanded within the CNS. The rapid recruitment of antigen-specific T cells into the CNS and their subsequent expansion may simply reflect the large quantity of N protein produced. Alternatively, the unique nature of the infection may result in a localized induction and expansion of these cells.
Local expansion of defined T-cell subsets has previously been postulated to account for the limited TCR diversity detected in the CNS of patients with multiple sclerosis (31) . Recent evidence has suggested that astrocytes can prime CD8+ but not CD4+ T cells (35) , supporting the possibility of local expansion of N protein-specific CD8+ CTL. Previous studies, using either injection of soluble proteins (7) or viral infections (27) which result in a predominant meningitis, have implicated the CLN as the major draining lymph nodes for the CNS. By contrast, JHMV produces a predominant encephalomyelitis associated with virus replication in oligodendroglia and astrocytes, with only minimal meningitis (25, 49) .
Whether the site of virus replication or the cell types infected influence the CTL component of the immune response is not known; however, proliferative responses to JHMV within the CLN can be detected at least as early as 5 days p.i. (51) . These data show the presence of JHMV-specific CTL which do not recognize any of the individual viral structural proteins in the spleen and CLN. This finding is not surprising, given the large proportion of the MHV genome encoding nonstructural proteins (approximately 23 of the 32 kb total). However, the low frequency of CD8+ CTL lines specific for a nonstructural protein(s) (2 of 19) suggests that thesc cells are not efficiently recruited into the CNS during JHMV infection and may reflect differences in adhesion molecule expression.
